Jubilant Drug Discovery Center operations started in North America.
Jubilant Discovery Services has completed an important step in the realization of its long-term strategy to extend capabilities in prosecuting ion channel targets by opening up its discovery center in North America, JDC-NA ( Jubilant Discovery Center – North America ) , JDC – NA is equipped with full range of enabling platforms and related expertise in prosecuting ion channel targets. This center is also enabled with comprehensive discovery biology capabilities with a focus in Voltage gated and ligand gated ion channels, GPCRs and Kinases.
Ion channel screening capabilities using electrophysiology and atomic absorption spectroscopy
Assay development, validation, medium- high-throughput screening, comprehensive cell-culture related capabilities, etc.
Jubilant approach to prosecute Ion channel targets: